Edwards Lifesciences gains amid takeover speculation
- Edwards Lifesciences (NYSE:EW) quickly rose 2.8% amid some vague takeover speculation.
- Edwards (EW) may have attracted takeover interest from an unnamed suitor, according to traders, who cited a Betaville “uncooked alert” circulating on Monday.
- Edwards Lifesciences (EW) has a market cap of $41 billion.